Medication info

MultiPlus 5 Weeks

Prescription medicationInjectionsIntravenous injectionApproval withdrawn
Ingredient · strength
Zinc Sulfate Hydrate›4.39mg / 1mLCopper Sulfate›1.57mg / 1mLManganese Sulfate›0.308mg / 1mLChromic Chloride Hydrate›20.5μg / 1mLSelenious Acid›32.7μg / 1mL
Manufacturer / importer
NBK Pharmaceutical Co., Ltd.
Appearance
Colorless, transparent vial injection containing a colorless or slightly blue transparent liquid with no odor.
Packaging
10 milliliters / vial [X 10], 20 milliliters / vial [X 10]
Approval status
Approval withdrawn

MFDS item code 201903232 · Notified 2019.05.20

This product's status changed to Approval withdrawn on 2024.04.19. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Prevention of trace element deficiencies (e.g., zinc and copper) during intravenous nutrition
Who receives it
Adults · Children
Adult administration
Use as prescribed by a physician, and check plasma trace element levels to guide dose adjustment. Permitted dosage range (for intravenous administration): Patients receiving parenteral nutrition who are metabolically stable Zinc: 2.5~4mg per day Copper: 0.5~1.5mg per day Manganese: 0.15~0.8mg per day Chromium: 10~15㎍ per day Selenium: 20~40㎍ per day Patients with small bowel fluid losses who are metabolically stable: additionally, 12.2mg/L (small bowel fluid loss) or 17.1mg/kg (stool output) Patients with acute catabolic conditions: 4.5~6mg per day Patients with small bowel fluid losses who are metabolically stable: 20㎍ per day Deficiency due to long-term parenteral nutrition: 100㎍ per day may be used for 24~31 days.
Child administration
Age 5 years or younger: zinc 100㎍/kg of body weight per day, copper 20㎍/kg of body weight per day, manganese 2~10㎍/kg of body weight per day, chromium 0.14~0.20㎍/kg of body weight per day, selenium 3㎍/kg of body weight per day

Ingredients

Manufacturer
NBK Pharmaceutical Co., Ltd.

Efficacy & effects

Prevention of trace element deficiencies (e.g., zinc and copper) during intravenous nutrition

View approved original text

By properly supplying trace elements such as zinc, copper, manganese, selenium, and chromium during intravenous nutritional supply, it helps facilitate metabolic functions in the body, contributes to immune enhancement and tissue recovery. These trace elements play an important role in supporting essential enzyme functions in the body and improving nutritional status. Therefore, nutrient solutions that include trace elements during intravenous nutritional supply effectively contribute to overall health maintenance and recovery.

How it is given

Adult administration

Use as prescribed by a physician, and check plasma trace element levels to guide dose adjustment. Permitted dosage range (for intravenous administration): Patients receiving parenteral nutrition who are metabolically stable Zinc: 2.5~4mg per day Copper: 0.5~1.5mg per day Manganese: 0.15~0.8mg per day Chromium: 10~15㎍ per day Selenium: 20~40㎍ per day Patients with small bowel fluid losses who are metabolically stable: additionally, 12.2mg/L (small bowel fluid loss) or 17.1mg/kg (stool output) Patients with acute catabolic conditions: 4.5~6mg per day Patients with small bowel fluid losses who are metabolically stable: 20㎍ per day Deficiency due to long-term parenteral nutrition: 100㎍ per day may be used for 24~31 days.

Child administration

Age 5 years or younger: zinc 100㎍/kg of body weight per day, copper 20㎍/kg of body weight per day, manganese 2~10㎍/kg of body weight per day, chromium 0.14~0.20㎍/kg of body weight per day, selenium 3㎍/kg of body weight per day

Precautions

This medication should not be administered to premature infants and newborns because it contains benzyl alcohol, which can cause respiratory problems in premature infants. This medication must be diluted before injection into the vein to prevent phlebitis; direct intravenous injection should not be performed. It is also a hypotonic solution and should only be used for mixed injections. If toxic symptoms appear during drug administration, it should be discontinued immediately. Special caution is needed for patients with impaired kidney function or premature infants as there is a higher risk of toxicity due to aluminum accumulation. Before administration, physicians should carefully evaluate the patient's condition and the required amount of trace elements, frequently check blood trace element concentrations, and adjust the dosage accordingly. Patients with impaired kidney or biliary function may have difficulty excreting zinc, copper, manganese, chromium, and selenium, which can lead to toxicity, so caution is advised. The safety of this medication has not been sufficiently confirmed in pregnant women or women of childbearing potential; therefore, it should only be administered cautiously when the benefits outweigh the risks. In case of overdose, toxic symptoms related to zinc, copper, chromium, and selenium may occur, and immediate consultation with medical staff is required for appropriate measures. This medication must be used according to a doctor's prescription, and it is important to maintain an aseptic state when adding it to non-oral nutritional solutions. Before administration, check for discoloration or particulate matter in the solution; if abnormalities are found, it should not be used.

Side effects

  • Shortness of breath
  • sweating
  • decreased consciousness
  • blurred vision
  • tachycardia
  • hypothermia
  • hyperamylasemia
  • hypotension
  • pulmonary edema
  • diarrhea
Show 31 more
  • vomiting
  • jaundice
  • decreased urine output
  • exhaustion
  • behavioral changes
  • progressive wasting syndrome
  • photophobia
  • peripheral edema
  • nausea
  • ulcer
  • gastrointestinal disturbances
  • renal impairment
  • liver dysfunction
  • convulsions
  • coma
  • hair loss
  • nail weakness
  • dermatitis
  • dental damage
  • irritability
  • depression
  • metallic taste
  • sweating
  • garlic breath upon respiration
  • acute peripheral vascular collapse
  • vascular congestion
  • pulmonary hemorrhage
  • pulmonary congestion
  • pulmonary edema
  • gastric mucosal discoloration
  • coma

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container to prevent air or moisture intrusion. It is recommended to maintain a storage temperature between 15 to 30 degrees Celsius.

Appearance and packaging

Appearance

Colorless, transparent vial injection containing a colorless or slightly blue transparent liquid with no odor.

Package unit

10 milliliters / vial [X 10], 20 milliliters / vial [X 10]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.